FEBS Letters
Volume 582, Issue 10 , Pages 1425-1430, 30 April 2008

Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: Insight into integrase–DNA complex formation and catalysis

Edited by Jacomine Krijnse-Locker

  • Laith Q. Al-Mawsawi

      Affiliations

    • Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA 90089, USA
  • ,
  • Frauke Christ

      Affiliations

    • The Laboratory for Molecular Virology and Gene Therapy, KULeuven and IRC KULAK, Kapucijnenvoer 33, B-3000 Leuven, Flanders, Belgium
  • ,
  • Raveendra Dayam

      Affiliations

    • Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA 90089, USA
  • ,
  • Zeger Debyser

      Affiliations

    • The Laboratory for Molecular Virology and Gene Therapy, KULeuven and IRC KULAK, Kapucijnenvoer 33, B-3000 Leuven, Flanders, Belgium
  • ,
  • Nouri Neamati

      Affiliations

    • Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA 90089, USA
    • Corresponding Author InformationCorresponding author. Fax: +1 323 442 1390.

Received 24 October 2007; received in revised form 18 February 2008; accepted 29 February 2008. published online 10 March 2008.

Abstract 

A lens epithelium-derived growth factor (LEDGF)/p75 peptide was evaluated for human immunodeficiency virus type 1 integrase (IN) inhibitory activity. The LEDGF/p75 peptide modestly inhibited IN catalysis and was dependent on IN–DNA assembly. The peptide was also effective at disrupting LEDGF/p75–IN complex formation. We next investigated the activity of the LEDGF/p75 peptide on IN mutant proteins that are unable to catalyze the DNA strand transfer reaction. The LEDGF/p75 peptide displayed an increased potency on these IN proteins, from 5-fold to greater than 10-fold, indicating the IN multimeric state greatly influences the peptide inhibitory effects. These results shed light on IN–DNA multimeric formation, and how this process influences the LEDGF/p75–IN interaction.

Abbreviations: HIV-1, human immunodeficiency virus type 1, IN, integrase, WT, wild-type, LEDGF, lens epithelium-derived growth factor, IBD, integrase binding domain

Keywords: HIV-1, Integrase, Cellular cofactor, LEDGF/p75, Peptide, Peptidomimetic

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(08)00199-3

doi:10.1016/j.febslet.2008.02.076

FEBS Letters
Volume 582, Issue 10 , Pages 1425-1430, 30 April 2008